Search details
1.
Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE).
Breast Cancer Res
; 25(1): 2, 2023 01 11.
Article
in English
| MEDLINE | ID: mdl-36631725
2.
ASTEFANIA: adjuvant ado-trastuzumab emtansine and atezolizumab for high-risk, HER2-positive breast cancer.
Future Oncol
; 18(32): 3563-3572, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-36382554
3.
Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial.
Lancet Oncol
; 21(10): 1283-1295, 2020 10.
Article
in English
| MEDLINE | ID: mdl-33002436
4.
HER2 Copy Number and Resistance Mechanisms in Patients with HER2-positive Advanced Gastric Cancer Receiving Initial Trastuzumab-based Therapy in JACOB Trial.
Clin Cancer Res
; 29(3): 571-580, 2023 02 01.
Article
in English
| MEDLINE | ID: mdl-36413222
5.
Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer.
Clin Cancer Res
; 29(8): 1569-1581, 2023 04 14.
Article
in English
| MEDLINE | ID: mdl-36730339
6.
Monoclonal antibodies against the human somatostatin receptor subtypes 1-5: development and immunohistochemical application in neuroendocrine tumors.
Neuroendocrinology
; 95(3): 232-47, 2012.
Article
in English
| MEDLINE | ID: mdl-22156600
7.
Atezolizumab With Neoadjuvant Anti-Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial.
J Clin Oncol
; 40(25): 2946-2956, 2022 09 01.
Article
in English
| MEDLINE | ID: mdl-35763704
8.
Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE.
NPJ Breast Cancer
; 8(1): 106, 2022 Sep 19.
Article
in English
| MEDLINE | ID: mdl-36117201
9.
Corrected versus total body weight for dosage of sugammadex in morbidly obese patients. A randomized, double-blind, controlled trial.
Minerva Anestesiol
; 87(3): 371-373, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33325220
10.
Evaluation of somatostatin receptor subtype expression in human neuroendocrine tumors using two sets of new monoclonal antibodies.
Regul Pept
; 187: 35-41, 2013 Nov 10.
Article
in English
| MEDLINE | ID: mdl-24188818
11.
Will PAXgene substitute formalin? A morphological and molecular comparative study using a new fixative system.
J Clin Pathol
; 66(2): 124-35, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23125305
12.
Differential control of Notch1 gene transcription by Klf4 and Sp3 transcription factors in normal versus cancer-derived keratinocytes.
PLoS One
; 5(4): e10369, 2010 Apr 28.
Article
in English
| MEDLINE | ID: mdl-20442780
13.
EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer.
Nat Cell Biol
; 10(8): 902-11, 2008 Aug.
Article
in English
| MEDLINE | ID: mdl-18604200
Results
1 -
13
de 13
1
Next >
>>